Literature DB >> 32652296

Liver resection in Cirrhotic liver: Are there any limits?

Albert Chan1, Alfred Kow2, Taizo Hibi3, Fabrizio Di Benedetto4, Alejandro Serrablo5.   

Abstract

Liver resection remains one of the most technically challenging surgical procedure in abdominal surgery due to the complex anatomical arrangement in the liver and its rich blood supply that constitutes about 20% of the cardiac output per cycle. The challenge for resection in cirrhotic livers is even higher because of the impact of surgical stress and trauma imposed on borderline liver function and the impaired ability for liver regeneration in cirrhotic livers. Nonetheless, evolution and advancement in surgical techniques as well as knowledge in perioperative management of liver resection has led to a substantial improvement in surgical outcome in recent decade. The objective of this article was to provide updated information on the recent developments in liver surgery, from preoperative evaluation, to technicality of resection, future liver remnant augmentation and finally, postoperative management of complications.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  ALPPS; Associating liver partition and portal vein ligation for staged heaptectomy; Bile leakage; Cirrhosis; Hepatectomy; Hepatocellular carcinoma; ICG; Liver failure; Liver resection; Portal vein embolization; Robotic liver surgery; Volumetry

Mesh:

Year:  2020        PMID: 32652296     DOI: 10.1016/j.ijsu.2020.06.050

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  7 in total

Review 1.  [Living related liver transplantation].

Authors:  H-M Tautenhahn; F Rauchfuß; A Ali Deeb; A Bauschke; U Settmacher
Journal:  Chirurg       Date:  2020-11       Impact factor: 0.955

2.  A Mesenchymal-Epithelial Transition Factor-Agonistic Antibody Accelerates Cirrhotic Liver Regeneration and Improves Mouse Survival Following Partial Hepatectomy.

Authors:  Kuai Ma; Weitao Que; Xin Hu; Wen-Zhi Guo; Er-Li Gu; Liang Zhong; Virginia Morello; Manuela Cazzanti; Paolo Michieli; Terumi Takahara; Xiao-Kang Li
Journal:  Liver Transpl       Date:  2021-10-12       Impact factor: 6.112

3.  MMP2/9 downregulation is responsible for hepatic function recovery in cirrhotic rats following associating liver partition and portal vein ligation for staged hepatectomy.

Authors:  Yugang Qin; Chonghui Li; Xinlan Ge; Qiang Zhang; Xiaojun Wei; Rong Liu
Journal:  Ann Transl Med       Date:  2022-04

4.  Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma.

Authors:  Xiaoyuan Chen; Yiwei Lu; Xiaoli Shi; Xuejiao Chen; Dawei Rong; Guoyong Han; Long Zhang; Chuangye Ni; Jie Zhao; Yun Gao; Xuehao Wang
Journal:  J Oncol       Date:  2021-12-10       Impact factor: 4.375

5.  Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma.

Authors:  Jian Wang; Yiwen Qiu; Yi Yang; Shu Shen; Ming Zhi; Bo Zhang; Wentao Wang
Journal:  Cancer Med       Date:  2022-04-12       Impact factor: 4.711

6.  Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool.

Authors:  Amirkasra Mojtahed; Luis Núñez; John Connell; Alessandro Fichera; Rowan Nicholls; Angela Barone; Mariana Marieiro; Anthony Puddu; Zobair Arya; Carlos Ferreira; Ged Ridgway; Matt Kelly; Hildo J Lamb; Felipe Caseiro-Alves; J Michael Brady; Rajarshi Banerjee
Journal:  Abdom Radiol (NY)       Date:  2021-10-04

7.  Liver transplantation and hepatobiliary surgery in 2020.

Authors:  Burcin Ekser; Karim J Halazun; Henrik Petrowsky; Deniz Balci
Journal:  Int J Surg       Date:  2020-07-19       Impact factor: 13.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.